Skip to main content
Clinical Trials/CTRI/2021/04/033272
CTRI/2021/04/033272
Completed
未知

A PILOT CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF THE SIDDHA FORMULATION â??NEERIZHUVU CHOORANAMâ?? NEERIZHIVU (TYPE II DIABETIS MELLITUS)

SHARMILA P0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
SHARMILA P
Enrollment
20
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 10, 2017
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
SHARMILA P

Eligibility Criteria

Inclusion Criteria

  • 2 Polyphagia
  • 3 Polydipsia
  • 4 loss of weight
  • 5 HbA1c â?? 6\.4 TO 10%

Exclusion Criteria

  • 1 Age less than 15 years
  • 2 Above 60 years
  • 3 Presence of CVS RS Liver and Renal disease
  • 4 Other systemic illness Vulnerable groups
  • 5 Not willing to give informed consent
  • 6 Women those who are planning for pregnancy
  • 7 HbA1c less than 6\.4%
  • 8 IDDM Signature

Outcomes

Primary Outcomes

Not specified

Similar Trials